Fate Therapeutics IncNASDAQ:FATE
- LAST PRICE5.4400
- TODAY'S CHANGE (%)0.0400 (0.7407%)
- Bid / Lots5.1400/ 4
- Ask / Lots5.6500/ 1
- Open / Previous Close5.5900 / 5.4000
- Day Range
- 52 Week Range
- Volume1,440,307
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FATE |
|---|---|---|
| 09:32 ET | 13296 | 5.53 |
| 09:34 ET | 2000 | 5.49 |
| 09:36 ET | 6527 | 5.62 |
| 09:38 ET | 5912 | 5.63 |
| 09:39 ET | 8686 | 5.68 |
| 09:41 ET | 26764 | 5.73 |
| 09:43 ET | 13133 | 5.69 |
| 09:45 ET | 18499 | 5.795 |
| 09:48 ET | 4650 | 5.83 |
| 09:50 ET | 14298 | 5.865 |
| 09:52 ET | 5232 | 5.86 |
| 09:54 ET | 22130 | 5.85 |
| 09:56 ET | 5390 | 5.865 |
| 09:57 ET | 2064 | 5.8 |
| 09:59 ET | 2705 | 5.75 |
| 10:01 ET | 7782 | 5.86 |
| 10:03 ET | 4031 | 5.85 |
| 10:06 ET | 6126 | 5.84 |
| 10:08 ET | 4195 | 5.77 |
| 10:10 ET | 14940 | 5.75 |
| 10:12 ET | 3986 | 5.785 |
| 10:14 ET | 13689 | 5.75 |
| 10:15 ET | 20253 | 5.77 |
| 10:17 ET | 5354 | 5.78 |
| 10:19 ET | 18937 | 5.7 |
| 10:21 ET | 3441 | 5.675 |
| 10:24 ET | 9726 | 5.6291 |
| 10:26 ET | 9830 | 5.67 |
| 10:28 ET | 3752 | 5.68 |
| 10:30 ET | 2300 | 5.635 |
| 10:32 ET | 5255 | 5.6 |
| 10:33 ET | 4737 | 5.61 |
| 10:35 ET | 9238 | 5.59 |
| 10:37 ET | 674 | 5.615 |
| 10:39 ET | 8157 | 5.6399 |
| 10:42 ET | 6030 | 5.65 |
| 10:44 ET | 6776 | 5.67 |
| 10:46 ET | 1781 | 5.65 |
| 10:48 ET | 7679 | 5.645 |
| 10:50 ET | 5281 | 5.58 |
| 10:51 ET | 6705 | 5.545 |
| 10:53 ET | 2873 | 5.55 |
| 10:55 ET | 2233 | 5.56 |
| 10:57 ET | 2716 | 5.575 |
| 11:00 ET | 3642 | 5.595 |
| 11:02 ET | 5587 | 5.585 |
| 11:04 ET | 3334 | 5.56 |
| 11:06 ET | 3288 | 5.58 |
| 11:08 ET | 1566 | 5.57 |
| 11:09 ET | 3587 | 5.59 |
| 11:11 ET | 1516 | 5.575 |
| 11:13 ET | 1685 | 5.56 |
| 11:15 ET | 4188 | 5.545 |
| 11:18 ET | 4584 | 5.55 |
| 11:20 ET | 1360 | 5.56 |
| 11:22 ET | 6010 | 5.525 |
| 11:24 ET | 922 | 5.565 |
| 11:26 ET | 1208 | 5.565 |
| 11:27 ET | 2838 | 5.555 |
| 11:29 ET | 2175 | 5.565 |
| 11:31 ET | 19485 | 5.585 |
| 11:33 ET | 4882 | 5.58 |
| 11:36 ET | 1725 | 5.59 |
| 11:38 ET | 7070 | 5.6582 |
| 11:40 ET | 3766 | 5.64 |
| 11:42 ET | 3874 | 5.64 |
| 11:44 ET | 500 | 5.645 |
| 11:45 ET | 4685 | 5.65 |
| 11:47 ET | 1402 | 5.64 |
| 11:49 ET | 2800 | 5.63 |
| 11:51 ET | 700 | 5.625 |
| 11:54 ET | 400 | 5.625 |
| 11:56 ET | 3154 | 5.61 |
| 11:58 ET | 11244 | 5.62 |
| 12:00 ET | 2372 | 5.615 |
| 12:02 ET | 2299 | 5.605 |
| 12:03 ET | 6241 | 5.585 |
| 12:05 ET | 4314 | 5.55 |
| 12:07 ET | 2559 | 5.545 |
| 12:09 ET | 5555 | 5.545 |
| 12:12 ET | 4416 | 5.535 |
| 12:14 ET | 11456 | 5.49 |
| 12:16 ET | 3652 | 5.5 |
| 12:18 ET | 1008 | 5.495 |
| 12:20 ET | 3785 | 5.505 |
| 12:21 ET | 814 | 5.505 |
| 12:23 ET | 896 | 5.505 |
| 12:25 ET | 7517 | 5.495 |
| 12:27 ET | 2266 | 5.495 |
| 12:30 ET | 16014 | 5.485 |
| 12:32 ET | 3202 | 5.485 |
| 12:34 ET | 2700 | 5.48 |
| 12:36 ET | 7363 | 5.465 |
| 12:38 ET | 6743 | 5.45 |
| 12:39 ET | 1260 | 5.4403 |
| 12:41 ET | 12457 | 5.45 |
| 12:43 ET | 5155 | 5.4749 |
| 12:45 ET | 8463 | 5.475 |
| 12:48 ET | 1183 | 5.47 |
| 12:50 ET | 1000 | 5.45 |
| 12:52 ET | 300 | 5.445 |
| 12:54 ET | 511 | 5.445 |
| 12:56 ET | 2050 | 5.44 |
| 12:57 ET | 2827 | 5.435 |
| 12:59 ET | 4797 | 5.445 |
| 01:01 ET | 7055 | 5.435 |
| 01:03 ET | 4161 | 5.425 |
| 01:06 ET | 1773 | 5.44 |
| 01:08 ET | 2729 | 5.42 |
| 01:10 ET | 900 | 5.405 |
| 01:12 ET | 2269 | 5.405 |
| 01:14 ET | 1408 | 5.405 |
| 01:15 ET | 1700 | 5.405 |
| 01:17 ET | 4330 | 5.415 |
| 01:19 ET | 3762 | 5.395 |
| 01:21 ET | 6882 | 5.38 |
| 01:24 ET | 10900 | 5.365 |
| 01:26 ET | 5853 | 5.405 |
| 01:28 ET | 12906 | 5.355 |
| 01:30 ET | 16319 | 5.425 |
| 01:32 ET | 7928 | 5.405 |
| 01:33 ET | 4686 | 5.405 |
| 01:35 ET | 5578 | 5.38 |
| 01:37 ET | 1294 | 5.385 |
| 01:39 ET | 700 | 5.385 |
| 01:42 ET | 9247 | 5.385 |
| 01:44 ET | 2125 | 5.38 |
| 01:46 ET | 14302 | 5.41 |
| 01:48 ET | 25993 | 5.4 |
| 01:50 ET | 3343 | 5.375 |
| 01:51 ET | 3311 | 5.365 |
| 01:53 ET | 2100 | 5.385 |
| 01:55 ET | 1700 | 5.395 |
| 01:57 ET | 2215 | 5.395 |
| 02:00 ET | 602 | 5.395 |
| 02:02 ET | 2083 | 5.395 |
| 02:04 ET | 18798 | 5.435 |
| 02:06 ET | 4441 | 5.435 |
| 02:08 ET | 6496 | 5.455 |
| 02:09 ET | 7246 | 5.465 |
| 02:11 ET | 1956 | 5.465 |
| 02:13 ET | 994 | 5.465 |
| 02:15 ET | 1829 | 5.48 |
| 02:18 ET | 3308 | 5.485 |
| 02:20 ET | 3127 | 5.48 |
| 02:22 ET | 1500 | 5.46 |
| 02:24 ET | 200 | 5.465 |
| 02:26 ET | 6893 | 5.475 |
| 02:27 ET | 2054 | 5.465 |
| 02:29 ET | 1200 | 5.46 |
| 02:31 ET | 949 | 5.455 |
| 02:33 ET | 1000 | 5.45 |
| 02:36 ET | 1947 | 5.465 |
| 02:38 ET | 1500 | 5.465 |
| 02:40 ET | 2190 | 5.47 |
| 02:42 ET | 2215 | 5.45 |
| 02:44 ET | 1131 | 5.46 |
| 02:45 ET | 5600 | 5.465 |
| 02:47 ET | 1400 | 5.455 |
| 02:49 ET | 1155 | 5.46 |
| 02:51 ET | 3956 | 5.475 |
| 02:54 ET | 308 | 5.475 |
| 02:56 ET | 4895 | 5.485 |
| 02:58 ET | 4945 | 5.495 |
| 03:00 ET | 2627 | 5.485 |
| 03:02 ET | 2842 | 5.48 |
| 03:03 ET | 2218 | 5.49 |
| 03:05 ET | 5245 | 5.455 |
| 03:07 ET | 1940 | 5.48 |
| 03:09 ET | 1200 | 5.495 |
| 03:12 ET | 7782 | 5.505 |
| 03:14 ET | 3749 | 5.525 |
| 03:16 ET | 6909 | 5.505 |
| 03:18 ET | 3831 | 5.505 |
| 03:20 ET | 2014 | 5.495 |
| 03:21 ET | 5856 | 5.515 |
| 03:23 ET | 5642 | 5.525 |
| 03:25 ET | 1100 | 5.525 |
| 03:27 ET | 13225 | 5.505 |
| 03:30 ET | 1100 | 5.505 |
| 03:32 ET | 5364 | 5.49 |
| 03:34 ET | 3700 | 5.46 |
| 03:36 ET | 5649 | 5.465 |
| 03:38 ET | 4192 | 5.4689 |
| 03:39 ET | 1051 | 5.465 |
| 03:41 ET | 8171 | 5.47 |
| 03:43 ET | 1561 | 5.465 |
| 03:45 ET | 21959 | 5.495 |
| 03:48 ET | 11463 | 5.475 |
| 03:50 ET | 4783 | 5.47 |
| 03:52 ET | 13099 | 5.48 |
| 03:54 ET | 24599 | 5.435 |
| 03:56 ET | 15274 | 5.435 |
| 03:57 ET | 31372 | 5.435 |
| 03:59 ET | 163411 | 5.44 |
Jul 2, 2024
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4), from 4:01PM ET on Tuesday Jul 02, 2024 by Dow Jones
4:01PM ET on Tuesday Jul 02, 2024 by Dow Jones
Jun 26, 2024
DJ Fate Therapeutics Down Over 11%, on Pace for Largest Percent Decrease Since January 2023 -- Data Talk, from 1:44PM ET on Wednesday Jun 26, 2024 by Dow Jones
1:44PM ET on Wednesday Jun 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fate Therapeutics Inc | 614.7M | -2.8x | --- |
Contineum Therapeutics Inc | 541.5M | 27.6x | --- |
SAGE Therapeutics Inc | 630.1M | -1.3x | --- |
Urogen Pharma Ltd | 673.5M | -4.8x | --- |
Y-mAbs Therapeutics Inc | 541.1M | -25.3x | --- |
Zymeworks Inc | 751.6M | -6.0x | --- |
Company Information
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Contact Information
- Headquarters
- 12278 Scripps Summit DriveSAN DIEGO, CA, United States 92131
- Phone
- 858-875-1803
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- William Rastetter
- President, Chief Executive Officer, Chief Financial Officer, Principal Financial and Accounting Officer, Director
- John Wolchko
- Independent Vice Chairman of the Board
- John Mendlein
- General Counsel, Corporate Secretary
- Cindy Tahl
- Chief Research and Development Officer
- Bahram Valamehr
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $614.7M |
|---|---|
Revenue (TTM) | $6.5M |
Shares Outstanding | 113.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.80 |
EPS | $-1.92 |
Book Value | $3.74 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 94.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,287.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
